NCT01907360View on ClinicalTrials.gov

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Attention-Deficit Hyperactivity Disorder
Interventions
DRUG

HLD200 (methylphenidate hydrochloride)

Trial Locations (1)

89128

Centre for Psychiatry & Behavioral Medicine, Inc., Las Vegas

Sponsors
All Listed Sponsors
lead

Ironshore Pharmaceuticals and Development, Inc

OTHER